Case Report of a Patient with Mauriac Syndrome

Main Article Content

Suprianto Suryono
Muhammad Umer Malik
Chee Kwang Yung
Edwin Lim Chyi Chyuan
Pg Adli Pg Metussin

Abstract

We would like to present an interesting and rare case of a 16-year boy, with the background of Type 1 diabetes since the age of 11 years who presented with Diabetic Ketoacidosis (DKA). He had multiple admissions with DKA in the preceding two years and his liver function tests were found to be deranged during the last two presentations. This was further evaluated through various investigations and a diagnosis of Mauriac syndrome was made.

Keywords:
Diabetic ketoacidosis, chronic disorder, type 1 diabetes child, mauriac syndrome.

Article Details

How to Cite
Suryono, S., Malik, M. U., Yung, C. K., Chyuan, E. L. C., & Metussin, P. A. P. (2021). Case Report of a Patient with Mauriac Syndrome. Asian Journal of Case Reports in Medicine and Health, 5(2), 7-13. Retrieved from https://journalajcrmh.com/index.php/AJCRMH/article/view/30163
Section
Case Study

References

Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promotion Perspectives. 2020;10(2):98-115.

Sherigar JM, Castro J, Yin YM, Guss D, Mohanty SR. Glycogenic hepatopathy: a narrative review World J Hepatol. 2018; 10(2):172-185

Ishizu Y, Zen Y, Harada K, Umemura T, Nakanuma Y. Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease. Seminars in Liver Disease. 2016; 36(03):229-241.

Murata F, Horie I, Ando T, Isomoto E, Hayashi H, Akazawa S, et al. A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepaticglycogen deposition including gradient-dual-echo MRI. Endocr J. 2012;59:669-676.
[PMID: 22673296]

Johnson SR, Cooper MN, Jones TW, et al. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control study. Diabetologia. 2013;56: 2392–2400.

Kim MS, Quintos JB. Mauriac syndrome: growth failure and type 1 diabetes mellitus. Pediatr Endocrinol Rev. 2008;5 (4):989–993.

Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome). Daneman D, Drash AL, Lobes LA, Becker DJ, Baker LM, Travis LB Diabetes Care. 1981;4(3):360-5.

Mauras N, Merimee T, Rogol AD. Function of the growth hormone-insulin-like growth factor 1 axis in the profoundly growth-retarded diabetic child: evidence for detective target organ responsiveness in the Mauriac syndrome. Metabolism. 1991;40:1106–1111.

Berman MC. Hepatic glycogen storage during uncontrolled diabetes mellitus. A case report. S Afr Med J. 1973;47:184-186. [PMID: 4684248].

MacDonald MJ, Hasan NM, Ansari IH, Longacre MJ, Kendrick MA, Stoker SW. Discovery of a genetic metabolic cause for Mauriac syndrome in type 1 diabetes. Diabetes. 2016;65:2051-2059
PMID: 27207549
DOI: 10.2337/db16-0099

Topaloglu O, Demiral S, Demir B, Akaren D. Mauriac Syndrome: Case Report and Review of the Literature. The Turkish Journal of Endocrinology and Metabolism. 2017;21(4):131–135.

Mauriac P. Grosventre, hepatomegalie, troubles de la croissance chez les enfants diabetques, traits depuisplusieursanbnees par l’insuline. Gaz Hebd Sci Med Bordeux. 1930;51:402.

Mahesh S, Karp RJ, Castells S, Quintos JB. Mauriac syndrome in a 3-year-old boy. Endocr Pracr. 2007;13:63–6.

Giordano S, Martocchia A, Toussan L, Stefanelli M, Pastore F, Devito A, et al. Diagnosis of hepatic glycogenosis in poorly controlled type 1 diabetes mellitus. World J Diabetes. 2014;5:882–8.